Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. (August 2017)

• Record Type: Journal Article
• Authors: Curtis, Elizabeth M.; Moon, Rebecca J.; Harvey, Nicholas C.; Cooper, Cyrus
• Is Part Of: International journal of orthopaedic and trauma nursing. Number 26(2017)
• Page Start: 7
• Page End: 17
• Publication Date: 2017-08
• Subjects: Osteoporosis -- Epidemiology -- Assessment -- Geography -- High fracture risk; Orthopedic nursing -- Periodicals; Wounds and injuries -- Nursing -- Periodicals; 616.7023105
• DOI: 10.1016/j.ijotn.2017.04.004
• Languages: English
• ISSNs: 1878-1241

Abstract

Abstract: Osteoporosis constitutes a major public health problem, through its association with age-related fractures, particularly of the hip, vertebrae, distal forearm and humerus. Substantial geographic variation has been noted in the incidence of osteoporotic fractures worldwide, with Western populations (North America, Europe and Oceania), reporting increases in hip fracture throughout the second half of the 20th century, with a stabilisation or decline in the last two decades. In developing populations however, particularly in Asia, the rates of osteoporotic fracture appears to be increasing. The massive global burden consequent to osteoporosis means that fracture risk assessment should be a high priority amongst health measures considered by policy makers. The WHO operational definition of osteoporosis, based on a measurement of bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA), has been used globally since the mid-1990s. However, although this definition identifies those at greatest individual risk of fracture, in the population overall a greater total number of fractures occur in individuals with BMD values above threshold for osteoporosis diagnosis. A number of web-based tools to enable the inclusion of clinical risk factors, with or without BMD, in fracture prediction algorithms have been developed to improve the identification of individuals at high fracture risk, the most commonly used globally being FRAX ® . Access to DXA, osteoporosis risk assessment, case finding and treatment varies worldwide, but despite such advances studies indicate that a minority of men and women at high fracture risk receive treatment. Importantly, research is ongoing to demonstrate the clinical efficacy and cost-effectiveness of osteoporosis case finding and risk assessment strategies worldwide. The huge burden caused by osteoporosis related fractures to individuals, healthcare systems and societies should provide a clear impetus for the progression of such approaches.